share_log

Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

Benzinga ·  Apr 29 10:42

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and lowers the price target from $12 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment